drugset / Trial / NCT02283801
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
RandomizedParallel-groupOpen-labelTreatment
Summary
Single centre, open-label, multiple doses, one-sequence design study in two parallel groups of healthy volunteers
Timeline
- Start
- 2006-11
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | — |
| Subject | Lamotrigine | Small molecule | 150 mg | — |